Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor

2010 ◽  
Vol 29 (1) ◽  
pp. 185-192 ◽  
Author(s):  
Kaoru Irisa ◽  
Katsuhiro Masago ◽  
Yosuke Togashi ◽  
Shiro Fujita ◽  
Yukimasa Hatachi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth

scholarly journals Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer

2019 ◽  
Vol 39 (4) ◽  
pp. 1767-1775 ◽  
Author(s):  
EISUKE KURIHARA ◽  
KAZUHIKO SHIEN ◽  
HIDEJIRO TORIGOE ◽  
TATSUAKI TAKEDA ◽  
YUTA TAKAHASHI ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth

scholarly journals Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure

2016 ◽  
Vol 107 (7) ◽  
pp. 1001-1005 ◽  
Author(s):  
Takahisa Kawamura ◽  
Hirotsugu Kenmotsu ◽  
Tetsuhiko Taira ◽  
Shota Omori ◽  
Kazuhisa Nakashima ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth
Sign in / Sign up

Export Citation Format

Share Document